Nasus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	69	-	-	-
Enterprise Value	72	-	-	-
Debt / Equity Ratio	-0.56	-0.56	-0.65	-0.56
Quick Ratio	0.10	0.10	0.05	0.05
Current Ratio	0.12	0.12	0.11	0.13
Return on Assets (ROA)	-116.06%	-116.06%	-166.52%	-
Buyback Yield / Dilution	0.43%	0.43%	-2.44%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q